Global Antihypertensive Drugs Market Size & Share to Surpass $39.5 Billion by 2030: Growing cases of hypertension globally to propel market demand by Facts & Factors
NEW YORK, Feb. 14, 2023 /PRNewswire/ -- As per Facts and Factors study, The global antihypertensive drugs market size was worth around USD 20.5 billion in 2021 and is predicted to grow to around USD 39.5 billion by 2030 with a compound annual growth rate (CAGR) of roughly 2.95% between 2022 and 2030.
Report Link with All Related Graphs & Charts: https://www.fnfresearch.com/antihypertensive-drugs-market
Antihypertensive Drugs Market: Overview
Hypertension is more commonly known as high blood pressure and is a highly prevalent medical condition that affects the arteries. The force of the blood flow in patients with high blood pressure against the artery walls is higher than normal which means that the heart has to work harder to effectively pump blood throughout the body. The blood pressure reading in hypertensive cases is around 130/80 millimeters of mercury (mmHg) or more.
In a perfectly healthy human, the blood pressure is 120/80 mmHg, whereas in the case of elevated blood pressure the pressure value will reach around 120 to 129 mmHg in the case of the top number and the bottom number will maximum reach 80 to 89 mmHg. If the top number increases to 130 mmHg to 139 mmHg and the bottom number lies between 80 to 89 mmHg, it means the patient is suffering from stage 1 hypertension. In stage 2 hypertension, the values are 140 mmHg or above in the case of the top number and 90 mmHg or above for lower values. If the blood pressure reaches 180/120 mmHg, then the case will be considered as a crisis or hypertensive emergency which requires immediate medical attention.
Get a Free Sample Report with All Related Graphs & Charts (with COVID 19 Impact Analysis): https://www.fnfresearch.com/sample/antihypertensive-drugs-market
As per the analysis shared by our research analyst, the global antihypertensive drugs market is estimated to grow annually at a CAGR of around 2.95% over the forecast period (2022-2030)
In terms of revenue, the global antihypertensive drugs market size was valued at around USD 20.5 billion in 2021 and is projected to reach USD 39.5 billion, by 2030.
The market is projected to grow at a significant rate due to growing cases of hypertension across the world
Based on disease source segmentation, primary hypertension was predicted to show maximum market share in the year 2021
Based on end-users segmentation, clinics were the leading users in 2021
On the basis of region, North America was the leading revenue generator in 2021
Facts and Factors published the latest report titled "Antihypertensive Drugs Market By Disease Source (Secondary Hypertension and Primary Hypertension), By Therapeutics (Angiotensin Receptor Blockers (ARBs), Diuretics, Beta Blockers, Angiotensin Converting Enzyme (ACE), Calcium Channel Blockers, Alpha Blockers, Vasodilators, and Renin Inhibitors), By End-Users (Clinics, Hospitals, and Homecare), and By Region - Global and Regional Industry Insights, Overview, Comprehensive Analysis, Trends, Statistical Research, Market Intelligence, Historical Data and Forecast 2022 – 2030" into their research database.
Global Antihypertensive Drugs Market: Growth Drivers
Growing cases of hypertension globally to propel market demand.
The global antihypertensive drugs market is projected to grow owing to the increasing cases of hypertension across the world. High blood pressure is a common but serious medical condition and as per statistics by the World Health Organization (WHO), more than 1.13 billion people are affected by the condition. Patients suffering from certain medical conditions like obesity or diabetes are at a higher risk of contracting hypertension. Due to the high mortality rate induced by hypertension, international health agencies and government bodies have initiated multiple programs to educate the population about the importance of medical treatment.
For instance, India has initiated the India Hypertension Control Initiative (IHCI) which is consistently working toward managing the widespread disease in the country The association is a joint collaboration between the Government of India, the Indian Council of Medical Research (ICMR), Ministry of Health & Family Welfare, Resolve to Save Lives (Technical partner), and WHO Country Office for India (WHO India).
Global Antihypertensive Drugs Market: Restraints
Lack of awareness to restrict market expansion.
The impact of the disease is more intense in lower or middle-income families who do not have the necessary access to quality medical care. There is also a significant lack of awareness related to the symptoms of the diseases, medical treatment to follow, and lifestyle choices which are further reinforced by the absence of essential medical treatment. For instance, a 2012 study published by the National Library of Medicine concluded that 17% of Canadian citizens were unaware that they had high blood pressure. 1 in 5 people had uncontrolled hypertension.
Directly Purchase a Copy of the Report @ https://www.fnfresearch.com/buynow/su/antihypertensive-drugs-market
Global Antihypertensive Drugs Market: Opportunities
Increasing research & development to provide higher growth opportunities.
Hypertension remains a serious medical condition that does not have a permanent cure which has led to the medical community conducting aggressive research to understand more about the causes of the disease and treatment plans. For instance, a research group at the University of Oulu discovered a new high-blood-pressure-inducing circuit that was previously unknown. The discovery was made in May 2022. The study was related to obesity and overweight and is expected to open more doors in the hypertension research field.
Global Antihypertensive Drugs Market: Challenges
Managing side-effects associated with antihypertensive drugs to challenge the market expansion.
One of the key challenges faced by the producers of antihypertensive drugs is the management of serious side effects associated with the consumption of the medicine. The growing cases of patients feeling dizzy or nervous after consuming antihypertensive drugs greatly act against the efficiency of the medicines. Other side effects include erection problems, consistent cough, headache, constipation, or diarrhea. Even though these may not be serious problems, they impact the patient's quality of life.
Global Antihypertensive Drugs Market: Segmentation
The global antihypertensive drugs market is segmented based on disease source, therapeutics, end-users, and region.
Based on disease source, the global market divisions are secondary hypertension and primary hypertension. In 2021, the global market was dominated by the latter due to higher reported cases and subsequent demand for accurate medical assistance. As per official reports, primary hypertension accounts for nearly 95% of all cases related to high blood pressure. In case, the cause of hypertension is not known, it is called primary hypertension however, there are certain influential risk factors like a sedentary lifestyle, smoking, improper management of stress, obesity, and poor diet. It is recommended to regularly get a blood pressure check since it remains impossible to zero down on one particular cause.
Based on end-users, the global market segments are clinics, hospitals, and home care. In 2021, the global market was dominated by the clinics segment since in most cases, hypertension is first detected during a routine check which can be taken care of by medical professionals at clinics. Severe cases are referred for hospitalization, which was the second leading segment in 2021. In primary hypertension cases, the condition can be managed by making some changes in lifestyle habits and taking regular medicines and they generally do not require critical care. Hypertension is responsible for over 10 million deaths annually.
Get More Insight before Buying@: https://www.fnfresearch.com/inquiry/antihypertensive-drugs-market
List of Key Players in Antihypertensive Drugs Market:
F. Hoffmann-La Roche Ltd.
Daiichi Sankyo Company Limited
Key questions answered in this report:
What are the growth rate forecast and market size for ANTIHYPERTENSIVE DRUGS Market?
What are the key driving factors propelling the ANTIHYPERTENSIVE DRUGS Market forward?
What are the most important companies in the ANTIHYPERTENSIVE DRUGS Market Industry?
What segments does the ANTIHYPERTENSIVE DRUGS Market cover?
How can I receive a free copy of the ANTIHYPERTENSIVE DRUGS Market sample report and company profiles?
Market size value in 2021
USD 20.5 Billion
Revenue forecast in 2030
USD 39.5 Billion
CAGR of almost 2.95 % 2022-2030
2016 – 2021
2022 – 2030
By Disease Source, Therapeutics, End-Users, and Region
Value (USD Billion), and Volume (Units)
Revenue in USD million/billion and CAGR from 2022 to 2030
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World
U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others
Sanofi S.A, F. Hoffmann-La Roche Ltd., Daiichi Sankyo Company Limited, Pfizer Inc., Actelion Ltd., and others.
Market growth drivers, restraints, opportunities, Porter's five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.
Avail of customized purchase options to meet your exact research needs.
Free Brochure: https://www.fnfresearch.com/ask-to-analyst/antihypertensive-drugs-market
In September 2022, Lupin, a leading drug maker, announced the launch of the company's generic hypertension medicine in the US market
In November 2022, Baxdrostat, a new antihypertensive drug was presented at the American Heart Association Scientific Sessions conference and published in the New England Journal of Medicine. The trial results for the drug have shown positive results
North America to lead with the highest market share.
The global antihypertensive drugs market is projected to register the highest growth in North America led by the growing research activities and investments in studying the disease and medical drugs with enhanced performance. The US market will be significantly driven by the rising approvals received by generic producers of the medicine from the US Food and Drugs Administration authority. In November 2022, Zydus Lifesciences, an Indian multinational drug manufacturing company, received FDA's approval to sell the medicine in the US market.
The company will market the medicine with multiple strengths. The approved treatment uses hydrochlorothiazide and bisoprolol fumarate in combination and has proven to be effective in managing the condition. As of September 2022, the tablets had made an annual sale of USD 27 million in the US. Generic medicines have been gaining a lot of global attention due to cost and performance efficiency.
Global ANTIHYPERTENSIVE DRUGS Market is segmented as follows:
Antihypertensive Drugs Market: By Disease Source Outlook (2022-2030)
Antihypertensive Drugs Market: By Therapeutics Outlook (2022-2030)
Angiotensin Receptor Blockers (ARBs)
Angiotensin Converting Enzyme (ACE)
Calcium Channel Blockers
Antihypertensive Drugs Market: By End-Users Outlook (2022-2030)
Antihypertensive Drugs Market: By Region Outlook (2022-2030)
Rest of Europe
Rest of Asia Pacific
Rest of Latin America
Middle East & Africa
Rest of Middle East & Africa
Press Release for Antihypertensive Drugs Market: https://www.fnfresearch.com/news/global-antihypertensive-drugs-market
Browse Other Related Research Reports from Facts and Factors
Weight Loss and Weight Management Market : According to the report published by Facts and Factors, the global weight loss and weight management market size was worth around USD 224.27 billion in 2021 and is predicted to grow to around USD 405.4 billion by 2030 with a compound annual growth rate (CAGR) of roughly 6.84% between 2022 and 2030.
Tumor Ablation Market : According to the report published by Facts and Factors, the global tumor ablation market size was worth around USD 1.35 billion in 2021 and is predicted to grow to around USD 4.69 billion by 2030 with a compound annual growth rate (CAGR) of roughly 13.59% between 2022 and 2030.
Psoriatic Arthritis Market : According to the report published by Facts and Factors, the global psoriatic arthritis market size was worth around USD 8.82 billion in 2021 and is predicted to grow to around USD 22.23 billion by 2030 with a compound annual growth rate (CAGR) of roughly 11.35% between 2022 and 2030.
Physiotherapy Equipment Market : According to the report published by Facts and Factors, the global physiotherapy equipment market size was worth around USD 19.05 billion in 2021 and is predicted to grow to around USD 34 billion by 2030 with a compound annual growth rate (CAGR) of roughly 6.7% between 2022 and 2030.
Kinase Inhibitor In Autoimmune Diseases Market : According to the report published by Facts and Factors, the global kinase inhibitor in autoimmune diseases market size was worth around USD 4.7 billion in 2021 and is predicted to grow to around USD 7.9 billion by 2030 with a compound annual growth rate (CAGR) of roughly 5.43% between 2022 and 2030.
Browse through Facts and Factors's coverage of the Global Healthcare Industry
Follow Us on: LinkedIn | Twitter | Facebook
Facts and Factors is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, and company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client's needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.
Facts and Factors
Tel: +1 347 690-0211
USA/Canada Toll-Free No. +44 2032 894158
View original content:https://www.prnewswire.com/news-releases/global-antihypertensive-drugs-market-size--share-to-surpass-39-5-billion-by-2030-growing-cases-of-hypertension-globally-to-propel-market-demand-by-facts--factors-301746398.html
SOURCE FnF Research